Cargando…
Head and Neck Squamous Cell Carcinoma Vaccine: Current Landscape and Perspectives
The treatment of unresectable or metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) has traditionally relied on chemotherapy or radiotherapy, yielding suboptimal outcomes. The introduction of immunotherapy has significantly improved HNSCC treatment, even if the long-term results cannot be defi...
Autores principales: | Meliante, Piero Giuseppe, Petrella, Carla, Fiore, Marco, Minni, Antonio, Barbato, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670496/ https://www.ncbi.nlm.nih.gov/pubmed/37998754 http://dx.doi.org/10.3390/cimb45110577 |
Ejemplares similares
-
Antioxidant Use after Diagnosis of Head and Neck Squamous Cell Carcinoma (HNSCC): A Systematic Review of Application during Radiotherapy and in Second Primary Cancer Prevention
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Diagnostic Predictors of Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Programmed Cell Death-Ligand 1 in Head and Neck Squamous Cell Carcinoma: Molecular Insights, Preclinical and Clinical Data, and Therapies
por: Meliante, Piero Giuseppe, et al.
Publicado: (2022) -
Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea
por: Meliante, Piero Giuseppe, et al.
Publicado: (2023) -
Oxidative Stress in Obstructive Sleep Apnea Syndrome: Putative Pathways to Hearing System Impairment
por: Mastino, Pierluigi, et al.
Publicado: (2023)